It is revealed that anlotinib could limit lung cancer cells to proliferate, invade, and migrate and can limit tumor growth by blocking the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) pathway [24]. The gene discussed is WNK2; the disease is lung carcinoma.